1. Top tier team working in a hot area
2. Compelling assets that are clinical, not pre clinical
3. Large TAM with small market cap
4. So far so good on safety front and encouraging phase 1 results given the context
I'll take my chances for now.
valuation thoughts, page-121
-
- There are more pages in this discussion • 260 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
-0.002(13.0%) |
Mkt cap ! $9.951M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.1¢ | 1.0¢ | $13.65K | 1.300M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 2625597 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 88904 | 3 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| CHM (ASX) Chart |